• Predictive value of the HIV phenotype and genotype and of amprenavir and lopinavir inhibitory quotients
  in heavily pretreated patients on a ritonavir-boosted dual protease inhibitor regimen.
  Barrail-Tran A, Morand-Joubert L, Poizat G, et al  Antimicrob Agents Chemother. 2008 Feb 19
• Determination of abacavir, amprenavir, didanosine, efavirenz, nevirapine, and stavudine concentration
  in human plasma by MALDI-TOF/TOF.
  Notari S, Mancone C, Alonzi T, et al   J Chromatogr B Analyt Technol Biomed Life Sci. 2008 Jan 16
• Influence of the Orosomucoid Polymorphism on Amprenavir Pharmacokinetics in HIV-infected
  Patients: ANRS104 Trial
  A Barrail-Tran, C Cosson, G Raguin, , et al  15th CROI

Guidelines

United States           Internet Documents   Public Health Service Task Force Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV  Transmission in the United States. Perinatal HIV Guidelines Working Group. November 2, 2007 Guidelines     Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy Perinatal HIV Guidelines Working Group. November 2, 2007 Guidelines ARV Drugs Main Page Main New/Newsworthy Home Page